Mary Beth Scholand
( out of 338 reviews )

Mary Beth Scholand, MD

Languages spoken: English

Clinical Locations

Primary Location

University of Utah Hospital

Pulmonary, Clinic 3
50 N Medical Dr
Salt Lake City , UT 84132
801-581-7806
Get Directions

Sugar House Health Center

1280 E. Stringham Avenue
Salt Lake City , UT 84106
801-581-2000
Get Directions

South Jordan Health Center

5126 West Daybreak Parkway
South Jordan , UT 84009
801-213-4500
Get Directions
Show 1 more location(s)

Farmington Health Center

165 N. University Ave.
Farmington , UT 84025
801-213-3200
Get Directions

  • Dr. Mary Beth Scholand, MD is an associate professor in Pulmonary Medicine. Her research and clinical interest is Interstitial Lung Disease. This interest encompasses Idiopathic Pulmonary Fibrosis, Autoimmune Lung Diseases and Sarcoidosis. She is the Director of the Interstitial Lung Disease Clinic. She runs clinical trials focused on a cure for Idiopathic Pulmonary Fibrosis. In addition, her research focuses on phenotypic factors and genetic factors associated with Chronic Obstructive Pulmonary Diseases and Interstitial Lung Diseases.

    Specialties

    Board Certification

    American Board of Internal Medicine (Sub: Pulmonary Disease)
    National Board of Medical Examiners

    Patient Rating

    4.9 /5
    ( out of 338 reviews )

    The patient rating score is an average of all responses on our patient experience survey. The rating averages scores for all questions about care from our providers.

    The scale on which responses are measured is 1 to 5 with 5 being the best score.

    Patient Comments

    Patient comments are gathered from our patient experience survey and displayed in their entirety. For the convenience of our visitors, some patient comments have been translated from their original language into English while preserving their original meaning as accurately as possible. Patients are de-identified for confidentiality and patient privacy.

    FARMINGTON HEALTH CENTER

    Dr. Scholand is an awesome doctor. She shows constant care and concern regarding all aspects of a patients health issues. She is willing to be of help and makes sure everything is done when it needs to be. I am so glad I was able to get her as my pulmonologist.

    UNIVERSITY HOSPITAL

    Dr. Scholand always makes me feel like she has my best interest in mind. She also has a staff that really looks out for her patients. I trust her with my healthcare. I would refer anyone to her that needed her services.

    SUGAR HOUSE HEALTH CENTER

    She is fantastic doctor, has taken great care with me

    UNIVERSITY HOSPITAL

    Dr. Scholand's experience and expertise make her a best bet if one has lung problems.

    SOUTH JORDAN HEALTH CENTER

    Dr Scholand saved my life. She is a wonderful doctor and very caring person.

    SUGAR HOUSE HEALTH CENTER

    I literally wouldn't trade Dr. Scholand for anyone else. She respects me as a person, not just a patient and allows me to make decisions that I'm comfortable with.

    FARMINGTON HEALTH CENTER

    Dr. Scholand, is working so hard on helping me fine anything that could help me, get better.

    SUGAR HOUSE HEALTH CENTER

    Professional, knowledgeable, very polite, an excellent physician!

    FARMINGTON HEALTH CENTER

    Dr Scholand is the best Dr I have.

  • Dr. Mary Beth Scholand, MD is an associate professor in Pulmonary Medicine. Her research and clinical interest is Interstitial Lung Disease. This interest encompasses Idiopathic Pulmonary Fibrosis, Autoimmune Lung Diseases and Sarcoidosis. She is the Director of the Interstitial Lung Disease Clinic. She runs clinical trials focused on a cure for Idiopathic Pulmonary Fibrosis. In addition, her research focuses on phenotypic factors and genetic factors associated with Chronic Obstructive Pulmonary Diseases and Interstitial Lung Diseases.

    Board Certification and Academic Information

    Academic Departments Internal Medicine -Professor
    Academic Divisions Public Health
    Board Certification
    American Board of Internal Medicine (Sub: Pulmonary Disease)
    National Board of Medical Examiners

    Education history

    Undergraduate Northwestern University B.S.
    Professional Medical Medicine - Washington University M.D.
    Internship Internal Medicine - Barnes Hospital Intern
    Residency Internal Medicine - Barnes Hospital Resident
    Fellowship Pulmonary Medicine - University of Utah School of Medicine Fellow

    Selected Publications

    Journal Article

    1. Patel NM, Kulkarni T, Dilling D, Scholand MB, Interstitial and Diffuse Lung Disease Network Steering Committee (2019). Preoperative Evaluation of Patients With Interstitial Lung Disease. Chest, 156(5), 826-833. (Read full publication)
    2. Maher TM, Costabel U, Glassberg MK, Kondoh Y, Ogura T, Scholand MB, Kardatzke D, Howard M, Olsson J, Neighbors M, Belloni P, Swigris J (2021). Phase 2 trial to assess lebrikizumab in patients with idiopathic pulmonary fibrosis. The European respiratory journal, 57(2), (Read full publication)
    3. Martinez FJ, Yow E, Flaherty KR, Snyder LD, Durheim MT, Wisniewski SR, Sciurba FC, Raghu G, Brooks MM, Kim DY, Dilling DF, Criner GJ, Kim H, Belloli EA, Nambiar AM, Scholand MB, Anstrom KJ, Noth I, CleanUP-IPF Investigators of the Pulmonary Trials Cooperative (2021). Effect of Antimicrobial Therapy on Respiratory Hospitalization or Death in Adults With Idiopathic Pulmonary Fibrosis: The CleanUP-IPF Randomized Clinical Trial. JAMA, 325(18), 1841-1851. (Read full publication)
    4. Wuyts W, Antin-Ozerkis D, Huggins JT, LaCamera PP, Spagnolo P, Va¿áková M, Wijsenbeek MS, Polman B, Kirchgaessler KU, Scholand M (2019). Serious adverse events in patients with idiopathic pulmonary fibrosis in the placebo arms of 6 clinical trials. Respiratory medicine, 150, 120-125. (Read full publication)
    5. Richeldi L, Scholand MB, Lynch DA, Colby TV, Myers JL, Groshong SD, Chung JH, Benzaquen S, Nathan SD, Davis JR, Schmidt SL, Hagmeyer L, Sonetti D, Hetzel J, Criner GJ, Case AH, Ramaswamy M, Calero K, Gauhar UA, Patel NM, Lancaster L, Choi Y, Pankratz DG, Walsh PS, Lofaro LR, Huang J, Bhorade SM, Kennedy GC, Martinez FJ, Raghu (2021). Utility of a Molecular Classifier as a Complement to High-Resolution Computed Tomography to Identify Usual Interstitial Pneumonia. American journal of respiratory and critical care medicine, 203(2), 211-220. (Read full publication)
    6. Swigris JJ, Andrae DA, Churney T, Johnson N, Scholand MB, White ES, Matsui A, Raimundo K, Evans C (2020). Development and Initial Validation Analyses of the Living with Idiopathic Pulmonary Fibrosis Questionnaire. American journal of respiratory and critical care medicine, 202(12), 1689-1697. (Read full publication)
    7. Rahaghi FF, Safdar Z, Brown AW, de Andrade JA, Flaherty KR, Kaner RJ, King CS, Padilla ML, Noth I, Scholand MB, Shifren A, Nathan S (2020). Expert consensus on the management of adverse events and prescribing practices associated with the treatment of patients taking pirfenidone for idiopathic pulmonary fibrosis: a Delphi consensus study. BMC pulmonary medicine, 20(1), 191. (Read full publication)
    8. Pettersson H, Alexanderson H, Poole JL, Varga J, Regardt M, Russell AM, Salam Y, Jensen K, Mansour J, Frech T, Feghali-Bostwick C, Varjú C, Baldwin N, Heenan M, Fligelstone K, Holmner M, Lammi MR, Scholand MB, Shapiro L, Volkmann ER, Saketkoo L (2021). Exercise as a multi-modal disease-modifying medicine in systemic sclerosis: An introduction by The Global Fellowship on Rehabilitation and Exercise in Systemic Sclerosis (G-FoRSS). Best practice & research. Clinical rheumatology, 35, 101695. (Read full publication)
    9. Rahaghi FF, Baughman RP, Saketkoo LA, Sweiss NJ, Barney JB, Birring SS, Costabel U, Crouser ED, Drent M, Gerke AK, Grutters JC, Hamzeh NY, Huizar I, Ennis James W 4th, Kalra S, Kullberg S, Li H, Lower EE, Maier LA, Mirsaeidi M, Müller-Quernheim J, Carmona Porquera EM, Samavati L, Valeyre D, Scholand M (2020). Delphi consensus recommendations for a treatment algorithm in pulmonary sarcoidosis. European respiratory review, 29(155), (Read full publication)
    10. Baughman RP, Scholand MB, Rahaghi F (2020). Clinical phenotyping: role in treatment decisions in sarcoidosis. European respiratory review, 29(155), (Read full publication)
    11. Rahaghi FF, Sweiss NJ, Saketkoo LA, Scholand MB, Barney JB, Gerke AK, Lower EE, Mirsaeidi M, O'Hare L, Rumbak MJ, Samavati L, Baughman R (2020). Management of repository corticotrophin injection therapy for pulmonary sarcoidosis: a Delphi study. European respiratory review, 29(155), (Read full publication)
    12. Richeldi L, Fernández Pérez ER, Costabel U, Albera C, Lederer DJ, Flaherty KR, Ettinger N, Perez R, Scholand MB, Goldin J, Peony Yu KH, Neff T, Porter S, Zhong M, Gorina E, Kouchakji E, Raghu (2020). Pamrevlumab, an anti-connective tissue growth factor therapy, for idiopathic pulmonary fibrosis (PRAISE): a phase 2, randomised, double-blind, placebo-controlled trial. The Lancet. Respiratory medicine, 8(1), 25-33. (Read full publication)
    13. Saketkoo LA, Russell AM, Jensen K, Mandizha J, Tavee J, Newton J, Rivera F, Howie M, Reese R, Goodman M, Hart P, Strookappe B, De Vries J, Rosenbach M, Scholand MB, Lammi MR, Elfferich M, Lower E, Baughman RP, Sweiss N, Judson MA, Drent (2021). Health-Related Quality of Life (HRQoL) in Sarcoidosis: Diagnosis, Management, and Health Outcomes. Diagnostics (Basel, Switzerland), 11(6), (Read full publication)
    14. Saketkoo LA, Scholand MB, Lammi MR, Russell A (2020). Patient-reported outcome measures in systemic sclerosis-related interstitial lung disease for clinical practice and clinical trials. Journal of scleroderma and related disorders, 5(2 Suppl), 48-60. (Read full publication)
    15. Saketkoo LA LA, Jensen K, Nikoletou D, Newton JJ, Rivera FJ, Howie M, Reese RK, Goodman M, Hart PB, Bembry W, Russell A, Lian I, Lammi MR, Scholand Mb MB, Russell Am A (2022). Sarcoidosis Illuminations on Living During COVID-19: Patient Experiences of Diagnosis, Management, and Survival Before and During the Pandemic. Journal of patient experience, 9, 23743735221075556. (Read full publication)
    16. Lee J, White E, Freiheit E, Scholand MB, Strek ME, Podolanczuk AJ, Patel NM, Pulmonary Fibrosis Foundation (2022). Cough-specific Quality of Life Predicts Disease Progression Among Patients with Interstitial Lung Disease: Data from the Pulmonary Fibrosis Foundation Patient Registry. Chest, (Read full publication)
    17. Gupta R, Baughman RP, Nathan SD, Wells AU, Kouranos V, Alhamad EH, Culver DA, Barney J, Carmona EM, Cordova FC, Huitema M, Scholand MB, Wijsenbeek M, Ganesh S, Birring SS, Price LC, Wort SJ, Shlobin O (2022). The six-minute walk test in sarcoidosis associated pulmonary hypertension: Results from an international registry. Respiratory medicine, 196, 106801. (Read full publication)
    18. Rahaghi FF, Kolaitis NA, Adegunsoye A, de Andrade J, Flaherty KR, Lancaster L, Lee JS, Levine D, Preston IR, Safdar Z, Saggar R, Sahay S, Scholand MB, Shlobin O, Zisman DA, Nathan S (2022). Screening Strategies for Pulmonary Hypertension in Patients With Interstitial Lung Disease: A Multidisciplinary Delphi Study. Chest, 162, 145-155. (Read full publication)
    19. Huitema MP, Post MC, Grutters JC, Wells AU, Kouranos V, Shlobin OA, Nathan SD, Culver DA, Barney J, Gupta R, Carmona E, Alhamad EH, Scholand MB, Wijsenbeek M, Ganesh S, Lower EE, Engel PJ, Baughman R (2022). Echocardiographic estimate of pulmonary artery pressure in sarcoidosis patients - real world data from a multi-national study. Sarcoidosis, vasculitis, and diffuse lung diseases, 38(4), e2021032. (Read full publication)
    20. Lasky JA, Case A, Unterman A, Kreuter M, Scholand MB, Chaudhary S, Lofaro LR, Johnson M, Huang J, Bhorade SM, Kennedy G (2021). The Impact of the Envisia Genomic Classifier in the Diagnosis and Management of Patients with Idiopathic Pulmonary Fibrosis. Annals of the American Thoracic Society, 19, 916-924. (Read full publication)
    21. Solomon JJ, Danoff SK, Woodhead FA, Hurwitz S, Maurer R, Glaspole I, Dellaripa PF, Gooptu B, Vassallo R, Cox PG, Flaherty KR, Adamali HI, Gibbons MA, Troy L, Forrest IA, Lasky JA, Spencer LG, Golden J, Scholand MB, Chaudhuri N, Perrella MA, Lynch DA, Chambers DC, Kolb M, Spino C, Raghu G, Goldberg HJ, Rosas IO, TRAIL1 Network Investigator (2023). Safety, tolerability, and efficacy of pirfenidone in patients with rheumatoid arthritis-associated interstitial lung disease: a randomised, double-blind, placebo-controlled, phase 2 study. The Lancet. Respiratory medicine, 11(1), 87-96. (Read full publication)
    22. Saketkoo LA, Escorpizo R, Varga J, Keen KJ, Fligelstone K, Birring SS, Alexanderson H, Pettersson H, Chaudhry HA, Poole JL, Regardt M, LeSage D, Sarver C, Lanario J, Renzoni E, Scholand MB, Lammi MR, Kowal-Bielecka O, Distler O, Frech T, Shapiro L, Varju C, Volkmann ER, Bernstein EJ, Drent M, Obi ON, Patterson KC, Russell AM, Global Fellowship on Rehabilitation and Exercise in Systemic Sclerosis (G-FoRSS (2022). World Health Organization (WHO) International Classification of Functioning, Disability and Health (ICF) Core Set Development for Interstitial Lung Disease. Frontiers in pharmacology, 13, 979788. (Read full publication)
    23. Raghu G, Montesi SB, Silver RM, Hossain T, Macrea M, Herman D, Barnes H, Adegunsoye A, Azuma A, Chung L, Gardner GC, Highland KB, Hudson M, Kaner RJ, Kolb M, Scholand MB, Steen V, Thomson CC, Volkmann ER, Wigley FM, Burlile D, Kemper KA, Knight SL, Ghazipura (2023). Treatment of Systemic Sclerosis-associated Interstitial Lung Disease: Evidence-based Recommendations. An Official American Thoracic Society Clinical Practice Guideline. American journal of respiratory and critical care medicine, (Read full publication)
    24. Gayen SK, Baughman RP, Nathan SD, Wells AU, Kouranos V, Alhamad EH, Culver DA, Barney J, Carmoma EM, Cordova FC, Huitema M, Scholand MB, Wijsenbeek M, Ganesh S, Birring SS, Price LC, Wort SJ, Shlobin OA, Gupta (2023). Pulmonary hemodynamics and transplant-free survival in sarcoidosis-associated pulmonary hypertension: Results from an international registry. Pulmonary circulation, 13(4), e12297. (Read full publication)
    25. Williamson J, Kelley K, Scholand MB, Crossno C, Hummert S, Jeppson P, Jacobson H, Buys (2025). Efficacy of a novel interstitial lung disease monitoring program in breast cancer patients undergoing treatment with trastuzumab-deruxtecan. Breast cancer research and treatment, 210(2), 487-491. (Read full publication)
    26. Lancaster L, Cottin V, Ramaswamy M, Wuyts WA, Jenkins RG, Scholand MB, Kreuter M, Valenzuela C, Ryerson CJ, Goldin J, Kim GHJ, Jurek M, Decaris M, Clark A, Turner S, Barnes CN, Achneck HE, Cosgrove GP, Lefebvre ÉA, Flaherty KR, PLN-74809-IPF-202 Trial Investigator (2024). Bexotegrast in Patients with Idiopathic Pulmonary Fibrosis: The INTEGRIS-IPF Clinical Trial. American journal of respiratory and critical care medicine, 210(4), 424-434. (Read full publication)
    27. Johnson SR, Bernstein EJ, Bolster MB, Chung JH, Danoff SK, George MD, Khanna D, Guyatt G, Mirza RD, Aggarwal R, Allen A Jr, Assassi S, Buckley L, Chami HA, Corwin DS, Dellaripa PF, Domsic RT, Doyle TJ, Falardeau CM, Frech TM, Gibbons FK, Hinchcliff M, Johnson C, Kanne JP, Kim JS, Lim SY, Matson S, McMahan ZH, Merck SJ, Nesbitt K, Scholand MB, Shapiro L, Sharkey CD, Summer R, Varga J, Warrier A, Agarwal SK, Antin-Ozerkis D, Bemiss B, Chowdhary V, Dematte D'Amico JE, Hallowell R, Hinze AM, Injean PA, Jiwrajka N, Joerns EK, Lee JS, Makol A, McDermott GC, Natalini JG, Oldham JM, Saygin D, Lakin KS, Singh N, Solomon JJ, Sparks JA, Turgunbaev M, Vaseer S, Turner A, Uhl S, Ivlev (2024). 2023 American College of Rheumatology (ACR)/American College of Chest Physicians (CHEST) Guideline for the Treatment of Interstitial Lung Disease in People with Systemic Autoimmune Rheumatic Diseases. Arthritis & rheumatology (Hoboken, N.J.), 76(8), 1182-1200. (Read full publication)
    28. Erlandson KM, Geng LN, Selvaggi CA, Thaweethai T, Chen P, Erdmann NB, Goldman JD, Henrich TJ, Hornig M, Karlson EW, Katz SD, Kim C, Cribbs SK, Laiyemo AO, Letts R, Lin JY, Marathe J, Parthasarathy S, Patterson TF, Taylor BD, Duffy ER, Haack M, Julg B, Maranga G, Hernandez C, Singer NG, Han J, Pemu P, Brim H, Ashktorab H, Charney AW, Wisnivesky J, Lin JJ, Chu HY, Go M, Singh U, Levitan EB, Goepfert PA, Nikolich J¿, Hsu H, Peluso MJ, Kelly JD, Okumura MJ, Flaherman VJ, Quigley JG, Krishnan JA, Scholand MB, Hess R, Metz TD, Costantine MM, Rouse DJ, Taylor BS, Goldberg MP, Marshall GD, Wood J, Warren D, Horwitz L, Foulkes AS, McComsey GA, RECOVER-Adult Cohor (2024). Differentiation of Prior SARS-CoV-2 Infection and Postacute Sequelae by Standard Clinical Laboratory Measurements in the RECOVER Cohort. Annals of internal medicine, 177(9), 1209-1221. (Read full publication)
    29. Johnson SR, Bernstein EJ, Bolster MB, Chung JH, Danoff SK, George MD, Khanna D, Guyatt G, Mirza RD, Aggarwal R, Allen A Jr, Assassi S, Buckley L, Chami HA, Corwin DS, Dellaripa PF, Domsic RT, Doyle TJ, Falardeau CM, Frech TM, Gibbons FK, Hinchcliff M, Johnson C, Kanne JP, Kim JS, Lim SY, Matson S, McMahan ZH, Merck SJ, Nesbitt K, Scholand MB, Shapiro L, Sharkey CD, Summer R, Varga J, Warrier A, Agarwal SK, Antin-Ozerkis D, Bemiss B, Chowdhary V, Dematte D'Amico JE, Hallowell R, Hinze AM, Injean PA, Jiwrajka N, Joerns EK, Lee JS, Makol A, McDermott GC, Natalini JG, Oldham JM, Saygin D, Lakin KS, Singh N, Solomon JJ, Sparks JA, Turgunbaev M, Vaseer S, Turner A, Uhl S, Ivlev (2024). 2023 American College of Rheumatology (ACR)/American College of Chest Physicians (CHEST) Guideline for the Treatment of Interstitial Lung Disease in People with Systemic Autoimmune Rheumatic Diseases. Arthritis care & research, 76(8), 1051-1069. (Read full publication)
    30. Johnson SR, Bernstein EJ, Bolster MB, Chung JH, Danoff SK, George MD, Khanna D, Guyatt G, Mirza RD, Aggarwal R, Allen A Jr, Assassi S, Buckley L, Chami HA, Corwin DS, Dellaripa PF, Domsic RT, Doyle TJ, Falardeau CM, Frech TM, Gibbons FK, Hinchcliff M, Johnson C, Kanne JP, Kim JS, Lim SY, Matson S, McMahan ZH, Merck SJ, Nesbitt K, Scholand MB, Shapiro L, Sharkey CD, Summer R, Varga J, Warrier A, Agarwal SK, Antin-Ozerkis D, Bemiss B, Chowdhary V, Dematte D'Amico JE, Hallowell R, Hinze AM, Injean PA, Jiwrajka N, Joerns EK, Lee JS, Makol A, McDermott GC, Natalini JG, Oldham JM, Saygin D, Lakin KS, Singh N, Solomon JJ, Sparks JA, Turgunbaev M, Vaseer S, Turner A, Uhl S, Ivlev (2024). 2023 American College of Rheumatology (ACR)/American College of Chest Physicians (CHEST) Guideline for the Screening and Monitoring of Interstitial Lung Disease in People with Systemic Autoimmune Rheumatic Diseases. Arthritis & rheumatology (Hoboken, N.J.), 76(8), 1201-1213. (Read full publication)
    31. Kulkarni T, Criner GJ, Kass DJ, Rosas IO, Scholand MB, Dilling DF, Summer R, Duncan S (2024). Design of the STRIVE-IPF trial- study of therapeutic plasma exchange, rituximab, and intravenous immunoglobulin for acute exacerbations of idiopathic pulmonary fibrosis. BMC pulmonary medicine, 24(1), 143. (Read full publication)
    32. Lancaster L, Cottin V, Ramaswamy M, Wuyts WA, Jenkins RG, Scholand MB, Kreuter M, Valenzuela C, Ryerson CJ, Goldin J, Kim GHJ, Jurek M, Decaris M, Clark A, Turner SM, Barnes CN, Achneck HE, Cosgrove GP, Lefebvre ÉA, Flaherty K (2024). Bexotegrast in people with idiopathic pulmonary fibrosis (IPF): a plain language summary of publication of the INTEGRIS-IPF study. Therapeutic advances in respiratory disease, 18, 17534666241287307. (Read full publication)
    33. Kulkarni T, Criner GJ, Kass DJ, Rosas IO, Scholand MB, Dilling DF, Summer R, Duncan S (2024). Design of the STRIVE-IPF Trial- Study of Therapeutic Plasma Exchange, Rituximab, and Intravenous Immunoglobulin for Acute Exacerbations of Idiopathic Pulmonary Fibrosis. Research square, (Read full publication)
    34. Johnson SR, Bernstein EJ, Bolster MB, Chung JH, Danoff SK, George MD, Khanna D, Guyatt G, Mirza RD, Aggarwal R, Allen A Jr, Assassi S, Buckley L, Chami HA, Corwin DS, Dellaripa PF, Domsic RT, Doyle TJ, Falardeau CM, Frech TM, Gibbons FK, Hinchcliff M, Johnson C, Kanne JP, Kim JS, Lim SY, Matson S, McMahan ZH, Merck SJ, Nesbitt K, Scholand MB, Shapiro L, Sharkey CD, Summer R, Varga J, Warrier A, Agarwal SK, Antin-Ozerkis D, Bemiss B, Chowdhary V, Dematte D'Amico JE, Hallowell R, Hinze AM, Injean PA, Jiwrajka N, Joerns EK, Lee JS, Makol A, McDermott GC, Natalini JG, Oldham JM, Saygin D, Lakin KS, Singh N, Solomon JJ, Sparks JA, Turgunbaev M, Vaseer S, Turner A, Uhl S, Ivlev (2024). 2023 American College of Rheumatology (ACR)/American College of Chest Physicians (CHEST) Guideline for the Screening and Monitoring of Interstitial Lung Disease in People with Systemic Autoimmune Rheumatic Diseases. Arthritis care & research, 76(8), 1070-1082. (Read full publication)

    Review

    1. Saketkoo LA, Frech T, Varjú C, Domsic R, Farrell J, Gordon JK, Mihai C, Sandorfi N, Shapiro L, Poole J, Volkmann ER, Lammi M, McAnally K, Alexanderson H, Pettersson H, Hant F, Kuwana M, Shah AA, Smith V, Hsu V, Kowal-Bielecka O, Assassi S, Cutolo M, Kayser C, Shanmugam VK, Vonk MC, Fligelstone K, Baldwin N, Connolly K, Ronnow A, Toth B, Suave M, Farrington S, Bernstein EJ, Crofford LJ, Czirják L, Jensen K, Hinchclif M, Hudson M, Lammi MR, Mansour J, Morgan ND, Mendoza F, Nikpour M, Pauling J, Riemekasten G, Russell AM, Scholand MB, Seigart E, Rodriguez-Reyna TS, Hummers L, Walker U, Steen (2021). A comprehensive framework for navigating patient care in systemic sclerosis: A global response to the need for improving the practice of diagnostic and preventive strategies in SSc. Best practice & research. Clinical rheumatology, 35(3), 101707. (Read full publication)
    2. Balakrishnan B, Callahan SJ, Cherian SV, Subramanian A, Sarkar S, Bhatt N, Scholand M (2023). Climate Change for the Pulmonologist: A Focused Review. Chest, (Read full publication)

    Case Report

    1. Werst D, Scarpato B, Callahan SJ, Scholand M (2021). A 64-Year-Old Man With Multifocal Infiltrates. Chest, 159(3), e151-e154. (Read full publication)

    Letter

    1. Saketkoo LA, Alexanderson H, Lammi MR, LeSage D, Jensen K, Scholand MB, Volkmann ER, Russell A (2020). An ode to the primal tonic of dance-congratulating the Life of Breath project. The Lancet. Respiratory medicine, 8(12), e90-e91. (Read full publication)
    2. Scholand MB, Wells A (2022). Comment on Idiopathic Pulmonary Fibrosis (an Update) and Progressive Pulmonary Fibrosis in Adults. American journal of respiratory and critical care medicine, 206(10), 1296. (Read full publication)

  • News & Podcasts

    News